Por: The Boston Globe Business June 06, 2023
The pharmaceutical company Merck on Tuesday sued the government over a federal law that empowers Medicare for the first time to negotiate prices directly with drug makers.Merck’s lawsuit, filed in federal court in Washington, is the drug industry’s most significant move so far to fight back against a substantial change to health policy, which will go into effect starting in 2026. Democrats pushed through the Medicare negotiation program last... + full article
CBS News USA Business June 07, 2023
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it extortion.The plan, part of the 2022 , is expected to save taxpayers on common drugs the government pays for. The law directs the Center for... + más
Merck sues U.S., calling Biden move to cut drug prices ‘extortion’ | Portland Press Herald
Merck sues over law empowering Medicare to negotiate with drug makers | The Boston Globe
Portland Press Herald USA World June 06, 2023
This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. AP Photo/Seth Wenig, File Merck is suing the U.S. over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies — a reform aimed at cutting costs... + más
Merck Tops Quarterly Profit Estimates but Sees Weaker 2023 Revenue on Lagevrio Sales Drop | MarketWatch
European committee: Regulators should deny Merck's Lagevrio | Associated Press
Associated Press USA Business April 27, 2023
Merck beat first-quarter expectations and hiked its 2023 forecast even as sales plunged for its COVID-19 treatment and a strong dollar hurt revenue. Soaring sales of the drugmaker’s top seller, the cancer treatment Keytruda, helped counter those hits, a drop expected by... + más
Merck has strong quarter even as COVID-19 treatment tumble | ABC News
ABC News USA Business April 27, 2023
Merck has strong quarter even as COVID-19 treatment tumble | Associated Press
Associated Press USA Health February 24, 2023
A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators.A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the... + más
Moderna, Merck announce progress in vaccine against skin cancer to significantly boost survival rate | ABC7
MarketWatch USA Business February 02, 2023
The company is expecting revenue to drop in 2023 amid a decline in sales of Lagevrio, its Covid-19 antiviral, and on Thursday set earnings guidance that was well below Wall Street expectations. Still, Merck Chief Financial Officer Caroline Litchfield said that the company’s... + más
Merck, Moderna detail potential skin cancer vaccine progress | WPLG Local 10
Merck, Moderna detail potential skin cancer vaccine progress | ABC News
Fox Business USA Business December 13, 2022
Rodney Smith Jr. and Yuri Williams discuss their mission to help children in need on 'Making Money with Charles Payne.' A Tuesday shows the vaccine-maker’s collaboration with biopharma Merck will help patients fight an aggressive form of skin cancer. In a joint... + más
Merck, Moderna detail potential skin cancer vaccine progress | Associated Press
About iurex | Privacy Policy | Disclaimer |